-The Times of India This may come as a shocker. Newer and more expensive categories of insulin are being aggressively "pushed" by drug companies, and, hence, increasingly prescribed by physicians for diabetics. The newer, second generation (rapid and long acting) versions are priced around Rs 500, three to four times costlier than the older versions - increasing the cost of treatment. Diabetes is growing alarmingly in India, with over 65 million...

-The Times of India NEW DELHI: India has eliminated maternal and neonatal tetanus. It has been reduced to less than one case per 1000 live births across the country, the World Health Organisation (WHO) has validated adding India to the list of countries that have successfully battled the DISEase. "This is a huge achievement for India which until a few decades ago reported 150,000 to 200,000 neonatal tetanus cases annually," WHO regional...

-The Indian Express The objective of the DNA Profiling Bill, 2015, is to establish a regulatory framework for DNA testing, and setting standards and guidelines for laboratories doing these tests. The proposed Human DNA Profiling Bill, 2015, could not be finalised in time to be introduced in Parliament’s Monsoon Session. After that, owing to the intense debate generated by the Bill in the past few weeks, the government extended the deadline...

-Hindustan Times Committed to serve only healthy 'langar' (food cooked in community kitchens of shrines) to devotees, the Shiromani Gurdwara Parbandhak Committee (SGPC) has declared its intention of producing organic seed of different types of food grains, vegetables and pulses, and then distributing these among farmers for growing in their agricultural fields. The SGPC may produce these organic seeds under the brand name, 'Shiromani', on agricultural land owned by it. The idea was...

-The Times of India NEW DELHI: A government task force has recommended changes in the existing drug price regulation which could result in a spike in prices of essential medicines. These include suggestions to pull several medicines out of price control, which is likely to impact drugs used in treatment of diabetes, cancer and cardiovascular DISEases as well as antibiotics. "There is a need to review the implementation of DPCO (Drugs Price...